Takeda Pharmaceutical Co Ltd (FRA:TKD)
€ 25.61 0.16 (0.63%) Market Cap: 40.44 Bil Enterprise Value: 65.50 Bil PE Ratio: 23.27 PB Ratio: 0.97 GF Score: 82/100

Takeda Pharmaceutical Co Ltd at Cowen Health Care Conference (Virtual) Transcript

Mar 08, 2022 / 07:50PM GMT
Release Date Price: €26.3 (-3.27%)
Kenneth Charles Cacciatore
Cowen and Company, LLC, Research Division - MD & Senior Research Analyst

Okay. Great. Thanks, everyone, for joining the Takeda fireside chat. We're really thrilled to have Andy and Ramona. Andy is President of R&D; and Ramona, President of the Global Portfolio Commercialization. So really fun discussion. I know offline, but always helping us is [Novi, Elizabeth and Sumi]. So we're really appreciative to them and all the help that they give us.

Questions & Answers

Kenneth Charles Cacciatore
Cowen and Company, LLC, Research Division - MD & Senior Research Analyst

Where we thought we'd start, Ramona, is one of the most interesting components of Takeda, I shouldn't say interesting, I think one of the things when you first start looking at and analyzing as an outsider like we did was there are a few exclusivities that are out there, some that are just certain like VYVANSE. There's nothing we can do about it and it's understood. And we understood the hemophilia portfolio and kind of the pressures.

But one

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot